Presented positive ReSPECT-GBM Phase 1/2 Trial update data at the 2024 Congress of Neurological Surgeons Annual Conference, ...
Announced promising safety and positive biomarker data from Cohort 2 (5mg BID) of the Phase 1b clinical trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) patients demonstrating dose dependent ...
DENVER, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the“Company”), a global leader in 3D geospatial products and intelligence solutions, today ...
Metalla Royalty & Streaming Ltd. ("Metalla" or the "Company") announces its operating and financial results for the three and nine months ended September 30, 2024. For complete details of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback